Literature DB >> 2966895

A retrovirus expressing the 12S adenoviral E1A gene product can immortalize epithelial cells from a broad range of rat tissues.

R D Cone1, T Grodzicker, M Jaramillo.   

Abstract

An epithelial cell-transforming virus could be of great use, both in the culture of epithelial cell lines and in the study of carcinogenesis. Since the adenoviral E1A gene has been shown to partially transform some epithelial cells from primary rat cell cultures, we constructed retrovirus vectors containing either the 12S or 13S E1A cDNA sequences to facilitate the transfer of these genes into a variety of primary cell types. The 12S E1A virus induced proliferation and immortalization of epithelial cells in rat kidney, liver, heart, pancreas, and thyroid primary cultures. In the two cases tested, heart and liver cultures, E1A-immortalized cells were nontumorigenic, but could be completely transformed by subsequent introduction of the ras oncogene. To our surprise, the 13S virus had a greatly reduced immortalization potential. We discuss these data in light of the model of Spindler et al. (K. R. Spindler, C. Y. Eng, and A.-J. Berk, J. Virol. 53:742-750, 1985), in which the 12S E1A protein is required for the complete induction of the cellular DNA replication machinery in the quiescent human epithelial cells in which adenoviruses normally replicate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966895      PMCID: PMC363246          DOI: 10.1128/mcb.8.3.1036-1044.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Lytic and transforming functions of individual products of the adenovirus E1A gene.

Authors:  E Moran; T Grodzicker; R J Roberts; M B Mathews; B Zerler
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  In vitro neoplastic transformation of uveal and retinal tissue by oncogenic DNA viruses.

Authors:  D M Albert; A S Rabson; A J Dalton
Journal:  Invest Ophthalmol       Date:  1968-08

3.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

4.  Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.

Authors:  M Perricaudet; G Akusjärvi; A Virtanen; U Pettersson
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

5.  Structure and function of the transforming genes of human adenoviruses and SV40.

Authors:  A J van der Eb; H van Ormondt; P I Schrier; J H Lupker; H Jochemsen; P J van den Elsen; R J DeLeys; J Maat; C P van Beveren; R Dijkema; A de Waard
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

6.  Inhibitors of glycosylation reverse retroviral interference.

Authors:  A Rein; A M Schultz; J P Bader; R H Bassin
Journal:  Virology       Date:  1982-05       Impact factor: 3.616

7.  Purification of kidney epithelial cell growth inhibitors.

Authors:  R W Holley; P Böhlen; R Fava; J H Baldwin; G Kleeman; R Armour
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

8.  Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site.

Authors:  C Montell; E F Fisher; M H Caruthers; A J Berk
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

9.  Tumorigenicity and in vitro characteristics of rat liver epithelial cells and their adenovirus-transformed derivatives.

Authors:  C Paraskeva; P H Gallimore
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

10.  Retinal tumor induced in the baboon by human adenovirus 12.

Authors:  N Mukai; S S Kalter; L B Cummins; V A Matthews; T Nishida; T Nakajima
Journal:  Science       Date:  1980-11-28       Impact factor: 47.728

View more
  22 in total

1.  Suppression of E1A-mediated transformation by the p50E4F transcription factor.

Authors:  E R Fernandes; R J Rooney
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.

Authors:  Melissa T Jack; Richard A Woo; Atsushi Hirao; Alison Cheung; Tak W Mak; Patrick W K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

3.  Isolation and immortalization of rat pre-type II cell lines.

Authors:  R K Mallampalli; C S Floerchinger; G W Hunninghake
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

4.  Adenovirus E1A is associated with a serine/threonine protein kinase.

Authors:  C H Herrmann; L K Su; E Harlow
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 5.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

6.  Maintenance of cellular proliferation by adenovirus early region 1A in fibroblasts conditionally immortalized by using simian virus 40 large T antigen requires conserved region 1.

Authors:  T E Riley; A Follin; N C Jones; P S Jat
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

7.  Establishment of an E1A-immortalized retinal cell culture.

Authors:  G M Seigel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-02       Impact factor: 2.416

8.  Recoverin expression in the R28 retinal precursor cell line.

Authors:  G M Seigel; A L Mutchler; G Adamus; E L Imperato-Kalmar
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

9.  Trilateral retinoblastoma in transgenic mice.

Authors:  J M O'Brien; D M Marcus; A S Niffenegger; R Bernards; J L Carpenter; J J Windle; P Mellon; D M Albert
Journal:  Trans Am Ophthalmol Soc       Date:  1989

10.  Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243- and 289-amino-acid proteins.

Authors:  Yongping Yang; Colin McKerlie; Steven H Borenstein; Zhan Lu; Marco Schito; John W Chamberlain; Manuel Buchwald
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.